Description générale
INN
Salbutamol
Codes ATC
Type de médicament
Chemical agent
Historique des statuts LME
Ajouté en 2003
(TRS
920)
pour
Chronic obstructive pulmonary disease
Wikipédia
DrugBank
Recommandations
Section
Antiasthmatic and medicines for chronic obstructive pulmonary disease
- Parenteral > General injections > IV: 50 µg per mL in 5 mL ampoule (as sulfate)
- Respiratory > Inhalation > aerosol: 100 µg per dose (as sulfate); 100 µg per dose (as sulfate) metered-dose inhaler
- Respiratory > Inhalation > solution: 5 mg per mL (as sulfate) for use in nebulizers
Indications